Home » Resources
Resources

OCT Conference Reflections: Embracing Gamification for Patient Engagement
Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.

Lighting the Way
How Replior’s integrated UV monitoring improves patient engagement in the Almirall AKtive trial, a phase IV study.

Advancing Cardiovascular Research with Trial Online EDC
The SCAPIS study collected and analyzed 30+ million data points from 30,154 participants with Replior.

Message from the CEO: Year in Review 2023
Reflecting on 2023, this CEO message highlights Replior’s achievements, lessons learned, and steps taken to prepare for future growth and innovation in clinical trials.

Low-Tech, High Impact: SMS’s Remarkable Open Rates Boost ePRO Compliance
SMS notifications in ePRO systems enhance clinical trial compliance by providing immediate, user-friendly reminders, leading to higher engagement and timely data submissions.

Solve Patient Retention, Compliance, and Data Quality Challenges in Clinical Trials
Download our eBook to solve retention, compliance, and data quality challenges in clinical trials with strategies from Replior experts.

The Distinct Roles of eCOA and ePRO in Decentralized Clinical Trials
Explore the roles of eCOA and ePRO in clinical trials, focusing on their impact on data collection, patient engagement, and patient-centric research.

Device Provisioning for Clinical Trials
Device provisioning ensures clinical trial participants have the devices they need, improving data collection, compliance, and inclusivity.

Increase Patient Engagement in Clinical Trials
Improving patient engagement in clinical trials increases retention and data quality through ePRO systems, gamification, and tailored notifications.

ePRO: The Data Collection Tool in Patient-Centric Trials
ePRO systems gather patient-reported data electronically, supporting engagement, compliance, and high-quality outcomes in patient-centric clinical trials.